PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,799 stories, page 67 of 814

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Hyundai Pharmaceutical Co., Ltd. Estimates – KRX:004310

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

fda making weight loss drugs harder to get

www.polskieradio.plOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

weight loss drug recently approved by fda

EMYOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cell Biotech Co., Ltd Estimates – KRX:049960

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

DakLak Pharmaceutical Medical Equipment JSC Estimates – UPCOM:DBM

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

newly fda approved weight loss drug

EMYOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China warnt vor Gegenmaßnahmen wegen ausgeweiteter US-Investitionsbeschränkungen für Biotech

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China warns of countermeasures over expanded US investment curbs on biotech

FXStreetOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Company Limited (TAK) stock price, news, quote and history

Yahoo Finance SingaporeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Welgene Biotech Co., Ltd. Estimates – TPEX:6661

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Navicare Biotech Co., Ltd. Estimates – TPEX:8472

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

KYUNG DONG PHARMACEUTICAL Co., Ltd Estimates – KRX:011040

TradingViewOriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Novo Nordisk filed Form 6-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

BioNTech filed Form 6-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

GSK filed Form 6-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Sanofi filed Form 6-K

SEC EDGAROriginal source
🌍Researchnature.comTier 2 · Direct publisher

Giving AI a seat at the peer review table

Nature BiotechnologyOriginal source
🇺🇰Researchnature.comTier 2 · Direct publisher

In vivo engineered CAR NK cells

Nature Reviews Drug DiscoveryOriginal source
🇺🇰Researchnature.comTier 2 · Direct publisher

Restoring antibiotic efficacy

Nature Reviews Drug DiscoveryOriginal source
🇺🇰Researchnature.comTier 2 · Direct publisher

Antagonizing adenosine receptors alleviates cardiac fibrosis

Nature Reviews Drug DiscoveryOriginal source
🇺🇰Researchnature.comTier 2 · Direct publisher

Nanotherapy targets senescent cells

Nature Reviews Drug DiscoveryOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Notice of Closed Meetings

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Fogarty International Center; Notice of Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Vida Janson, M.D.; Decision and Order

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Submission for Office of Management and Budget Review; Office of Refugee Resettlement (ORR) Unaccompanied Alien Child Health Forms

The Administration for Children and Families (ACF) Office of Refugee Resettlement (ORR) is requestin...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Barry Backiewicz, D.D.S.; Decision and Order

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ISEMBYLD (apitegromab-mstn)

The Food and Drug Administration (FDA) is announcing the issuance of a priority review voucher to th...

Federal RegisterOriginal source
🇺🇸Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Overcoming complications of polypropylene prolapse meshes: Development of novel elastomeric membranes

Recipient: UNIVERSITY OF PITTSBURGH AT PITTSBURGH. Award amount: 678530.

NIH RePORTEROriginal source
🇺🇸Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Elucidating the role of the hyaluronan on PGC development and ovarian reserve establishment

Recipient: UNIVERSITY OF PITTSBURGH AT PITTSBURGH. Award amount: 462856.

NIH RePORTEROriginal source
🇺🇸Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Regulatory mechanisms governing imprinted domains during early development

Recipient: UNIVERSITY OF PITTSBURGH AT PITTSBURGH. Award amount: 375940.

NIH RePORTEROriginal source
🇺🇸Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Identifying Molecular Signatures of Genomic Imprinting Errors

Recipient: UNIVERSITY OF PITTSBURGH AT PITTSBURGH. Award amount: 119044.

NIH RePORTEROriginal source
🇺🇸Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Development of a bioadhesive vaginal film for extended release of MPT antibodies

Recipient: UNIVERSITY OF PITTSBURGH AT PITTSBURGH. Award amount: 672881.

NIH RePORTEROriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: BM Colocynthis

Official structured record identifier: 38df8aed-a98d-0755-e063-6294a90a504b.

openFDA Drug LabelsOriginal source
🇺🇸Researchonlinejcf.comTier 2 · Direct publisher

DPP3 as a Biomarker in Patients with Cardiovascular Critical Illness

Journal of Cardiac FailureOriginal source
🇺🇸Researchonlinejcf.comTier 2 · Direct publisher

Prevalence and Timing of Palliative Care Provision For Decedents with Heart Failure - Trends from 2016 to 2022

Journal of Cardiac FailureOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Sequential Lidocaine and Liposomal Bupivacaine for Popliteal Sciatic Nerve Block in Foot and Ankle Surgery: A Randomized Controlled Trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Neuropsychiatric Safety of GLP-1 Receptor Agonists and Tirzepatide in Adults with Type 2 Diabetes Mellitus or Obesity.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Socioeconomic Status and Clinical Trial Enrollment in Head and Neck Cancer: A Single-Institution Retrospective Study.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Use of SGLT2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors in Incident Hyponatremia in Patients with Type 2 Diabetes: Multicenter Target Trial Emulations.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

An Integrated Artificial Intelligence Framework for Nanomedicine Engineering.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Tailoring Pain Self‑management for Chronic Pain and Opioid Use Disorder: Qualitative Insights from Patients and Clinicians.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Multiproperty optimization of therapeutic antibodies through sequence editing via large language model and reinforcement learning.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Primary non-adherence to newly prescribed discharge medications and 30-day adverse outcomes by mental health status: a retrospective cohort study in two tertiary care hospitals in Montréal, Québec, Canada.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Extended follow-up of tarlatamab in patients with small-cell lung cancer after platinum-based chemotherapy in the randomized phase III DeLLphi-304 study.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Impact of supplementation of a package of iron folic acid (IFA) with probiotics on haemoglobin levels in the elderly with mild to moderate anaemia: A double-blind, randomised controlled trial (PRobiotics in anaemia trial for healthy ageing Management - PRATHAM).

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Efzofitimod versus placebo in patients with pulmonary sarcoidosis (EFZO-FIT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

In vivo genome-editing therapy for Duchenne muscular dystrophy: Preclinical studies and first-in-human trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Cost-effectiveness of capivasertib plus abiraterone for PTEN-deficient metastatic hormone-sensitive prostate cancer in the United States.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Snake venom toxins in cancer therapy: advances in targeted delivery and peptide design.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Advancing Therapeutics for Children with Medical Complexity: The Role of Model-Informed Precision Dosing and Genotype-Stratified Trials.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

One-Year Outcomes of Chairside Fully Guided Versus Conventional Partially Guided Implant Placement With Transcrestal Sinus Augmentation: A Randomized Controlled Trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and <i>MET</i> Amplification: A Randomized Phase 3 Trial.

Europe PMCOriginal source
🌍Researchdoi.orgTier 1 · Research record

The Role of Counselors in Preventing Drug Abuse in Adolescents: A Systematic Literature Review

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Exploring the Benefits of Biophilic Design in Architectural Spaces for Drug Rehabilitation Centers

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Potentiation of the Immunostimulant Effect of Tetramisole: Revisiting Approach

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Effects of Secretome Administration on Serum Interleukin-6, Neurogranin, and Neurological Outcomes in Patients with Spinal Cord Injury: A Pilot Randomized Controlled Trial

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Left Atrial Reservoir Strain in Mitral Valve Prolapse: A Systematic Review and Meta-Analysis of Clinical, Pathophysiological, and Prognostic Implications

CrossrefOriginal source